Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Shares outstanding
-
9.65M
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
22M
-
Shares change
-
-3.93M
-
Total reported value, excl. options
-
$67M
-
Value change
-
-$100M
-
Put/Call ratio
-
0.31
-
Number of buys
-
57
-
Number of sells
-
-44
-
Price
-
$3.05
Significant Holders of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) as of Q2 2022
141 filings reported holding ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value as of Q2 2022.
Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22M shares
.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (4.8M shares), BlackRock Inc. (2.48M shares), RA CAPITAL MANAGEMENT, L.P. (1.88M shares), PATHSTONE FAMILY OFFICE, LLC (1.69M shares), VANGUARD GROUP INC (1.61M shares), BAKER BROS. ADVISORS LP (1.04M shares), STATE STREET CORP (910K shares), CITADEL ADVISORS LLC (849K shares), Bristlecone Advisors, LLC (701K shares), and GOLDMAN SACHS GROUP INC (581K shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.